CAS RN: 960404-86-8
Dapagliflozin Impurity 10
Product Availability
Choose a grade to view its available package options.
1 package records 0 with current stock 1 grade group
Grade
98% (1)
In stock only
Batch No. Package Availability Lead Time Inquiry
Batchno.20250423
5mg / 25mg / 100mg / 250mg
Out of stock
5-7 business days Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 0.25g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 960404-86-8
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
0.25g
≥95%
0
Out of Stock
Hong Kong
Inquiry
960404-86-8 / (2S,3R,4S,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-2,3,4,5-tetrol
Standard CAS: 960404-86-8
Multi CAS: Yes
Basic Information
copy
CAS
960404-86-8 copy
Multi CAS
Yes copy
Molecular Formula
C21H25CLO7 copy
Molecular Weight
424.900000 copy
Exact Mass
424.128881 copy
InChI
InChI=1S/C21H25ClO7/c1-2-28-15-6-3-12(4-7-15)9-13-10-14(5-8-16(13)22)21(27)20(26)19(25)18(24)17(11-23)29-21/h3-8,10,17-20,23-27H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1 copy
InChIKey
KYDGWGYAUCJZDV-ADAARDCZSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
29 copy
Aromatic heavy atom count
12 copy
Fraction Csp3
0.43 copy
Rotatable bonds
6 copy
H-bond acceptors
7 copy
H-bond donors
5 copy
Molar refractivity
105.75 copy
TPSA
119.61 copy
LogP / Solubility
WLOGP
0.95 copy
MLOGP
0.86 copy
XLogP3
1.6 copy
Consensus LogP
1.14 copy
Log S (ESOL)
-2.98 copy
Class (ESOL)
Moderately soluble copy
Log S (Ali)
-3.73 copy
Class (Ali)
Poorly soluble copy
Log S (SILICOS-IT)
-3.93 copy
Class (SILICOS-IT)
Poorly soluble copy
ADME
GI absorption
High copy
BBB permeant
No copy
P-gp substrate
Yes copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
No copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
No copy
Log Kp (skin permeation)
-4.64 copy
Drug-likeness / Medicinal Chemistry
Lipinski
Yes copy
Ghose
Yes copy
Veber
Yes copy
Egan
Yes copy
Muegge
Yes copy
Bioavailability score
0.55 copy
Leadlikeness
No copy
Synthetic Accessibility
5 copy